SCHEMBL299734

SCHEMBL299734

C=CCN(CC=C)c1ccccc1C=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
LMNA P02545 2/20 0.44
THRB P10828 1/20 0.44
BLM P54132 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 2/20 0.38
HTT P42858 1/20 0.38
C5AR1 P21730 1/20 0.38
TSHR P16473 1/20 0.38
TRIM24 O15164 1/20 0.38
TRIM33 Q9UPN9 1/20 0.38
PTPN1 P18031 1/20 0.36
KDM4E B2RXH2 1/20 0.35
POLB P06746 2/20 0.33
NPC1 O15118 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29082974 0.90 MEN1 (0.39) KMT2AMEN1LMNATHRBBLM
SCHEMBL473072 0.84 ALDH1A1 (0.40) KMT2AMEN1LMNAALDH1A1SMN1; SMN2
SCHEMBL7717165 0.84 PTPN1 (0.37) KMT2AMEN1LMNAALDH1A1SMN1; SMN2
SCHEMBL8582159 0.84 HPGD (0.40) LMNAALDH1A1SMN1; SMN2HPGDTSHR
SCHEMBL28398309 0.83 LMNA (0.43) KMT2AMEN1LMNATHRBBLM
SCHEMBL10583374 0.82 CDK4 (0.44) KMT2AMEN1LMNATHRBBLM
SCHEMBL5490438 0.81 KMT2A (0.41) KMT2AMEN1LMNATHRBBLM
SCHEMBL9289236 0.81 KMT2A (0.41) KMT2AMEN1LMNATHRBBLM
SCHEMBL6575512 0.81 C5AR1 (0.35) KMT2AMEN1LMNAALDH1A1SMN1; SMN2
SCHEMBL10715458 0.79 LMNA (0.43) KMT2AMEN1LMNATHRBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 350 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534839-B2 Sequentially terminated elastomers BRIDGESTONE CORPORATION (JP) 2009-05-19 US claimed
US-20080071091-A1 PROCESSES AND COMPOUNDS FOR THE PREPARATION OF SUBSTITUTED NAPHTHYLINDOLE DERIVATIVES WYETH (US) 2008-03-20 US claimed
EP-0890587-B1 Amine-initiated elastomers having a hysteresis reducing interaction with silica BRIDGESTONE CORP (JP) 2008-03-05 EP claimed
US-7323483-B2 Processes and compounds for the preparation of substituted naphthylindole derivatives WYETH (US) 2008-01-29 US claimed
EP-1856104-A1 PROCESSES AND COMPOUNDS FOR THE PREPARATION OF SUBSTITUTED NAPHTHYLINDOLE DERIVATIVES Wyeth a Corporation of the State of Delaware (US) 2007-11-21 EP claimed
JP-2007500281-A 2007-01-11 JP claimed
US-20060183917-A1 Processes and compounds for the preparation of substituted naphthylindole derivatives WYETH (US) 2006-08-17 US claimed
WO-2006081455-A1 PROCESSES AND COMPOUNDS FOR THE PREPARATION OF SUBSTITUTED NAPHTHYLINDOLE DERIVATIVES WYETH (US) 2006-08-03 WO claimed
US-20060135701-A1 Hysteresis elastomeric compositions comprising sequentially terminated polymers BRIDGESTONE CORPORATION (JP) 2006-06-22 US claimed
EP-1631596-A1 IMPROVED HYSTERESIS ELASTOMERIC COMPOSITIONS COMPRISING SEQUENTIALLY TERMINATED POLYMERS Bridgestone Corporation (JP) 2006-03-08 EP claimed
EP-0718321-A1 Anionic polymerization initiators and reduced hysteresis products therefrom BRIDGESTONE CORPORATION (JP) 1996-06-26 EP claimed
WO-1995032243-A1 POLYPHENYLENE ETHER BLENDS AND PROCESS FOR PRODUCING THEM OPTATECH CORPORATION (FI) 1995-11-30 WO claimed
EP-0626278-A1 Solubilized anionic polymerization initiators and products therefrom BRIDGESTONE CORPORATION (JP) 1994-11-30 EP claimed
EP-0622381-A1 Anionic polymerization initiators and reduced hysteresis products therefrom BRIDGESTONE CORPORATION (JP) 1994-11-02 EP claimed
EP-0593049-A1 Anionic polymerization initiators and reduced hysteresis products therefrom BRIDGESTONE CORPORATION (JP) 1994-04-20 EP claimed
EP-0590490-A1 Solubilized anionic polymerization initiators and products therefrom BRIDGESTONE CORPORATION (JP) 1994-04-06 EP claimed
EP-0299591-B1 PHOTOPOLYMERISABLE COMPOSITIONS AUTOTYPE INTERNATIONAL LIMITED (GB) 1993-01-13 EP claimed
US-5043362-A Polyvinyl alcohol modified with dialkylamino groups as hydrogen donor; screen printing stencils AUTOTYPE INTERNATIONAL LIMITED (GB) 1991-08-27 US claimed
EP-0299591-A2 Photopolymerisable compositions AUTOTYPE INTERNATIONAL LIMITED (GB) 1989-01-18 EP claimed
US-4083827-A Dialkylaminobenzaldehyde polypyrrolidone composition CHEVRON RESEARCH COMPANY (US) 1978-04-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080071091-A1 PROCESSES AND COMPOUNDS FOR THE PREPARATION OF SUBSTITUTED NAPHTHYLINDOLE DERIVATIVES SERPINE1, SERPINB1, TFPI KMT2A 2288/4885MEN1 1364/4885LMNA 737/4885
US-20060183917-A1 Processes and compounds for the preparation of substituted naphthylindole derivatives SERPINE1, SERPINB1, TFPI KMT2A 2288/4885MEN1 1364/4885LMNA 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.